{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T20:26:34Z","timestamp":1787430394434,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstertreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["F&S Reports"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.xfre.2026.06.003","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:47:51Z","timestamp":1781678871000},"page":"313-321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of desogestrel\/ethinylestradiol 150\/20 flexible extended regimen (FREEDOM 150\/20) in dysmenorrhea: phase 3 study in Japan"],"prefix":"10.1016","volume":"7","author":[{"given":"Kaori","family":"Koga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Colaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Grigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4921-3851","authenticated-orcid":false,"given":"Daisuke","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinghui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Momoeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xfre.2026.06.003_bib2","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1097\/AOG.0000000000002978","article-title":"Dysmenorrhea and endometriosis in the adolescent","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xfre.2026.06.003_bib3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2147\/IJWH.S380006","article-title":"Disease burden of dysmenorrhea: impact on life course potential","volume":"15","author":"MacGregor","year":"2023","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.xfre.2026.06.003_bib4","article-title":"Prevalence of menstrual pain and symptoms and their association with age and BMI among Japanese female app users","volume":"15","author":"Liu","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.xfre.2026.06.003_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0329154","article-title":"Effects of dysmenorrhea on work productivity and quality of life in Japanese women: a large-scale web-based cross-sectional study","volume":"20","author":"Nariai","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.xfre.2026.06.003_bib6","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/jog.13831","article-title":"Guidelines for office gynecology in Japan: Japan Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2017 edition","volume":"45","author":"Kawaguchi","year":"2019","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.xfre.2026.06.003_bib7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2147\/IJWH.S134576","article-title":"Efficacy and safety of a flexible extended regimen of ethinylestradiol\/drospirenone for the treatment of dysmenorrhea: a multicenter, randomized, open-label, active-controlled study","volume":"9","author":"Momoeda","year":"2017","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.xfre.2026.06.003_bib8","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1007\/s12325-022-02301-3","article-title":"Quality of life in Japanese patients with dysmenorrhea or endometriosis-associated pelvic pain treated with extended regimen ethinylestradiol\/drospirenone in a real-world setting: a prospective observational study","volume":"39","author":"Yoshino","year":"2022","journal-title":"Adv Ther"},{"key":"10.1016\/j.xfre.2026.06.003_bib9","author":"Buck"},{"key":"10.1016\/j.xfre.2026.06.003_bib10","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1007\/s12325-022-02298-9","article-title":"Efficacy of low-dose estrogen\u2013progestins and progestins in Japanese women with dysmenorrhea: a systematic review and network meta-analysis","volume":"39","author":"Iwata","year":"2022","journal-title":"Adv Ther"},{"key":"10.1016\/j.xfre.2026.06.003_bib13","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.fertnstert.2007.08.051","article-title":"Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial","volume":"90","author":"Harada","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2026.06.003_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0304-3959(86)90228-9","article-title":"The measurement of clinical pain intensity: a comparison of six methods","volume":"27","author":"Jensen","year":"1986","journal-title":"Pain"},{"key":"10.1016\/j.xfre.2026.06.003_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale","volume":"94","author":"Farrar","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.xfre.2026.06.003_bib16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1477-7525-7-36","article-title":"Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications","volume":"7","author":"Bharmal","year":"2009","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.xfre.2026.06.003_bib17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-ltem short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.xfre.2026.06.003_bib18","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1097\/00007632-200012150-00008","article-title":"SF-36 health survey update","volume":"25","author":"Ware","year":"2000","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.xfre.2026.06.003_bib19","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0895-4356(98)00081-X","article-title":"Overview of the SF-36 health survey and the International Quality of Life Assessment (IQOLA) project","volume":"51","author":"Ware","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.xfre.2026.06.003_bib21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/rmb2.12373","article-title":"Efficacy of cyclic and extended regimens of ethinylestradiol 0.02 mg -levonorgestrel 0.09 mg for dysmenorrhea: a placebo-controlled, double-blind, randomized trial","volume":"20","author":"Harada","year":"2021","journal-title":"Reprod Med Biol"},{"key":"10.1016\/j.xfre.2026.06.003_bib22","doi-asserted-by":"crossref","first-page":"5660","DOI":"10.3390\/jcm13195660","article-title":"Dysmenorrhea and its impact on patients\u2019 quality of life\u2014a cross-sectional study","volume":"13","author":"Amza","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.xfre.2026.06.003_bib23","first-page":"653","article-title":"Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial","volume":"101","author":"Miller","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xfre.2026.06.003_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0010-7824(03)00141-0","article-title":"A multicenter, randomized study of an extended cycle oral contraceptive","volume":"68","author":"Anderson","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.xfre.2026.06.003_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/aogs.12287","article-title":"Reduced quality of life when experiencing menstrual pain in women with primary dysmenorrhea","volume":"93","author":"Iacovides","year":"2014","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.xfre.2026.06.003_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2147\/IJWH.S238460","article-title":"Quality of life in Japanese patients with dysmenorrhea treated with ethinylestradiol 20 \u03bcg\/ drospirenone 3 mg in a real-world setting: an observational study","volume":"12","author":"Momoeda","year":"2020","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.xfre.2026.06.003_bib27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0010-7824(99)00097-9","article-title":"Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study","volume":"60","author":"Endrikat","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.xfre.2026.06.003_bib28","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/aogs.14384","article-title":"Systemic hormonal contraception and risk of venous thromboembolism","volume":"101","author":"Heikinheimo","year":"2022","journal-title":"Acta Obstet Gynecol Scand"}],"container-title":["F&S Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666334126001030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666334126001030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T20:14:25Z","timestamp":1787429665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666334126001030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2666334126001030"],"URL":"https:\/\/doi.org\/10.1016\/j.xfre.2026.06.003","relation":{},"ISSN":["2666-3341"],"issn-type":[{"value":"2666-3341","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of desogestrel\/ethinylestradiol 150\/20 flexible extended regimen (FREEDOM 150\/20) in dysmenorrhea: phase 3 study in Japan","name":"articletitle","label":"Article Title"},{"value":"F&S Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xfre.2026.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Reproductive Medicine.","name":"copyright","label":"Copyright"}]}}